Catalyst Wire Dossier Catalyst Wire Dossier

foslevodopa/foscarbidopa

foslevodopa/foscarbidopa · AbbVie
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for foslevodopa/foscarbidopa, covering 2025-08-05 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Change in Sleep Disturbances of Adult Participants With Advanced Parkinson's Disease Receiving Subcutaneous Foslevodopa/Foscarbidopa

See pricing